Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2021-09-13 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-09-13 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document announces the filing of Avicanna's unaudited interim financial statements for the three- and six-month period ended June 30, 2021, along with management's discussion and analysis and related certifications. It provides detailed corporate updates, including commercial progress, R&D, strategic partnerships, and an upcoming investor webinar. The document contains substantive financial and operational information for a period shorter than a full fiscal year, consistent with an interim or quarterly report. It is not merely an announcement of a report being published but includes detailed content and updates. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-09-10 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that InMed Pharmaceuticals will present at the H.C. Wainwright 23rd Annual Global Investment Conference. It includes details about the presentation date, access information, and contact details for investor relations. There is no financial data, no detailed report, no voting results, no regulatory filing, and no mention of an actual report being attached or published. The document is essentially an investor presentation announcement rather than the presentation itself. Given the content and length (3386 characters), it is not a full investor presentation (IP) but rather an announcement about an upcoming presentation. According to the classification rules, announcements about presentations or events are best classified as Regulatory Filings (RNS) if they do not fit other categories. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2021-09-10 English
Interim MD&A - English.pdf
Regulatory Filings
2021-09-10 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CFO of Avicanna Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2021. The document is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, including controls over financial reporting. It does not contain the actual interim financial statements or substantive financial data itself, but rather attests to their correctness. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself. The document length is 3755 characters, which is relatively short and consistent with a certification letter rather than a full interim report. Therefore, the correct classification is Regulatory Filings (RNS).
2021-09-10 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-09-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.